Award recordCONTRACT

VANDA PHARMACEUTICALS INC.

PIID 36E79724A0032· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $0 net obligations· UEI NG5JU1TQ3379· DC

Description

EXERCISE OPTION YEAR 2 - BPA 36E79724A0032

Base award description: BPA FOR HETLIOZ

First action · last action
2024-09-05 · 2026-07-28
Transactions
6
First transaction's obligation
$0
Base + all options value (sum of deltas)
$3,753,465
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79724D0191
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 6 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2024-09-05 · this action $0 · running total $0Modification P00001 · 2024-12-22 · this action $0 · running total $0Modification P00002 · 2025-07-11 · this action $0 · running total $0Modification P00003 · 2025-10-31 · this action $0 · running total $0Modification P00004 · 2025-12-16 · this action $0 · running total $0Modification P00005 · 2026-07-28 · this action $0 · running total $0
  • Base2024-09-05+$0= $0
  • Mod P000012024-12-22+$0= $0
  • Mod P000022025-07-11+$0= $0
  • Mod P000032025-10-31+$0= $0
  • Mod P000042025-12-16+$0= $0
  • Mod P000052026-07-28+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-09-05+$0$0BPA FOR HETLIOZ
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-22+$0$02025 PUBLIC LAW PRICING UPDATES
Mod P00002· EXERCISE AN OPTION2025-07-11+$0$0THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 1 ON BPA 36E79724A0032.
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-10-31+$0$0PRODUCT DELETION - HETLIOZ CAPSULES ONLY
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-12-16+$0$02026 PUBLIC LAW PRICING UPDATES.
Mod P00005· EXERCISE AN OPTION2026-07-28+$0$0EXERCISE OPTION YEAR 2 - BPA 36E79724A0032

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NG5JU1TQ3379)

AwardOffice · PSC / listingNet obligationsFY
36C26026F0025260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$26,344FY2026
36C26025F0002260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$131,068FY2025
36F79724D0191NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26024F0173260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$154,049FY2024
36C26023F0431260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$77,799FY2023
36E79722A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79724A0032_3600 · retrieved 2026-09-26.